Moreover, spatial transcriptomic/proteomic analyses could provide high-resolution insights into the spatial relationships between S100A14-expressing tumor cells and the immune landscape, not only in terms of immune cell composition but also their phenotypes within the tumor microenvironment. Here, S100A14 is linked to neoplasm.